Spectrum Pharmaceuticals, Inc. SPPI

NAS: SPPI | ISIN: US84763A1088   31/07/2023
1,030 USD (0,00%)
(0,00%)   31/07/2023

28 april 2023 · Moore Kuehn Encourages HOTH, HSKA, SPPI, and GLOP Investors to Contact Law Firm · Persbericht

27 januari 2023 · SPECTRUM SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Spectrum To Contact Him Directly To Discuss Their Options · Persbericht

24 januari 2023 · SPPI ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of February 3, 2023 in the Class Action Filed on Behalf of Spectrum Pharmaceuticals, Inc. Shareholders · Persbericht

23 januari 2023 · CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Spectrum Investors of a Lead Plaintiff Deadline of February 3, 2023 · Persbericht

6 januari 2023 · SPECTRUM DEADLINE ALERT : Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Spectrum To Contact Him Directly To Discuss Their Options · Persbericht

23 december 2022 · Spectrum Deadline Alert · Persbericht

14 december 2022 · Spectrum Deadline Alert · Persbericht

12 december 2022 · Bronstein, Gewirtz & Grossman, LLC Notifies Spectrum Pharmaceuticals, Inc. (SPPI) Investors of Class Action and to Actively Participate · Persbericht

12 december 2022 · Bronstein, Gewirtz & Grossman, LLC Notifies Spectrum Pharmaceuticals, Inc. (SPPI) Investors of Class Action and to Actively Participate · Persbericht

8 december 2022 · Spectrum Deadline Alert · Persbericht

6 december 2022 · Pomerantz Law Firm Investigates Claims On Behalf of Investors of Spectrum Pharmaceuticals, Inc. - SPPI · Persbericht

27 augustus 2022 · SPECTRUM PHARMACEUTICALS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Spectrum Pharmaceuticals, Inc. - SPPI · Persbericht

24 maart 2022 · Optimism Builds for Promising Developments & New Drug Therapies Targeting Treatments for Breast Cancer · Persbericht

27 januari 2022 · Constellation Energy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 · Persbericht

6 oktober 2021 · SPPI Investors Have Opportunity to Lead Spectrum Pharmaceuticals, Inc. Securities Fraud Lawsuit · Persbericht

20 september 2021 · SPPI CLASS ACTION DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. · Persbericht

15 september 2021 · Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. (SPPI) · Persbericht

11 september 2021 · ALERT: Spectrum Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Case - SPPI · Persbericht

8 september 2021 · SPPI ALERT: Spectrum Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Case · Persbericht

2 september 2021 · SPPI DEADLINE: Investors with Substantial Losses Have Opportunity to Lead the Spectrum Pharmaceuticals, Inc. Class Action Lawsuit · Persbericht

Mijn selecties